Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

GITRL RNA-transfected Autologous Dendritic Cell Vaccine

Known as: GITRL RNA DC, GITRL RNA-transfected Autologous DC 
An autologous dendritic cell (DC) cancer vaccine with potential immunostimulatory activity. GITRL RNA-transfected autologous DC vaccine is prepared… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
BackgroundGlucocorticoid-induced TNFR-related protein (TNFRSF18, GITR, CD357), expressed by T cells, and its ligand (TNFSF18… Expand
2019
2019
Glucocorticoid-induced TNFR-related protein (GITR, TNFRSF18, CD357), a TNFR-SF member, is a co-stimulatory receptor that… Expand
2017
2017
BackgroundThe expansion of antigen-specific CD8 T cells is important in generating an effective and long-lasting immune response… Expand
2016
2016
Adipose-derived mesenchymal stem cells (ASCs) are readily available multipotent mesenchymal progenitor cells and have become an… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2015
2015
............................................................................................................................... II ACKNOWLEDGEMENTS ..................................................................................................... IV TABLE OF CONTENTS ........................................................................................................... V LIST OF TABLES ................................................................................................................. VIII LIST OF FIGURES .................................................................................................................. IX LIST OF APPEDICES ............................................................................................................. XI LIST OF PUBLICATIONS AND PRESENTATIONS ........................................................ XII ABBREVIATIONS .................................................................................................................. XV CHAPTER 1: INTRODUCTION .............................................................................................. 2 PART I: THE CO-STIMULATORY TNFRSF MEMBER GITR .......................................................... 2 1.1. AN INTRODUCTION TO T CELL CO-STIMULATION AND THE TNFR FAMILY MEMBER GITR .. 2 1.2. EXPRESSION, REGULATION, AND STRUCTURAL FEATURES OF GITR AND GITRL ................ 3 1.3. INTRACELLULAR SIGNALING BY GITR ................................................................................. 4 1.4. STRUCTURE-FUNCTIONAL IMPLICATIONS OF GITR-GITRL INTERACTION ........................... 8 1.5. EFFECTS OF GITR-GITRL INTERACTIONS ON INNATE CELL SUBSETS .................................. 8 1.5.1. GITR-GITRL in innate inflammatory responses in vitro ............................................. 8 1.5.2. GITR-GITRL in leukocyte adhesion and migration .................................................... 9 1.5.3. Reverse signaling through GITRL in innate cells ..................................................... 10 1.5.4. Effect of GITR on NK and NKT cells ......................................................................... 11 1.6. THE ROLE OF GITR-GITRL ON B CELLS ........................................................................... 11 1.7. SIGNALING BY GITR ON REGULATORY AND CONVENTIONAL CD4 AND CD8 T CELLS. ..... 12 1.7.1. GITR co-stimulation of murine T cells ...................................................................... 12 1.7.2. Cross-regulation between GITR and other co-stimulatory molecules on T cells ...... 14 1.7.3. GITR co-stimulation of human T cells ....................................................................... 14 1.8. CELL-TYPE SPECIFIC EFFECTS OF GITR IN CANCER ............................................................ 15 1.8.1. GITR-targeted therapies for cancer .......................................................................... 15 1.8.2. Mechanisms of enhanced tumour immunity with GITR-targeted therapies .............. 16 1.8.3. GITR-GITRL in cancer immune evasion: modulating of NK and tumour cells ........ 17 1.9. GITR-GITRL IN INFLAMMATION, TRANSPLANTATION, ALLERGY, AND AUTOIMMUNITY ... 18 1.9.1. GITR-GITRL in inflammatory diseases ..................................................................... 18 1.9.2. GITR-GITRL in allergy ............................................................................................. 19 1.9.3. GITR-GITRL in models of colitis and autoimmunity ................................................. 19 1.9.4. Autoimmune models with Treg-extrinsic effects of GITR-GITRL ............................. 22 1.9.5. GITR-GITRL in tissue transplant models .................................................................. 23 1.9.6. Correlating GITR and GITRL expression in human autoimmune diseases .............. 24 
  • figure 1-1
  • figure 1-2
  • table 1-1
  • figure 1-3
  • figure 1-4
Review
2013
Review
2013
Interactions between several tumor necrosis factor (TNF)-TNF receptor (TNFR) superfamily members that are expressed by T cells… Expand
  • figure 1
Review
2010
Review
2010
The ability of the tumor necrosis factor receptor (TNFR) family member GITR to modulate immune responses has been the subject of… Expand
  • figure 1
Highly Cited
2009
Highly Cited
2009
The reciprocal interaction of tumor cells with the immune system is influenced by various members of the tumor necrosis factor… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
2006
2006
The glucocorticoid‐induced TNF‐related receptor ligand (GITRL) was previously shown to be constitutively expressed at low levels… Expand
2005
2005
The role of CD95 ligand (FasL/Apo‐1L)‐expressing tumors in immunosuppression or immunopotentiation is controversial. CD95L… Expand